Vote Scores
Filings read through

How funds voted at MapLight Therapeutics, Inc.

Ticker
MPLT
SEC company number
1770069
Filers reporting
63, year to 30 June 2026
Latest meeting on file
Meetings on file
1

In the year to 30 June 2026, 63 filers on Form N-PX reported votes at MapLight Therapeutics, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 124 marks to the ballot items, each with or against management. 98.4% of the marks are with management.

In the year to 30 June 2026, no say-on-pay item is on file for MapLight Therapeutics, Inc.. So there is no figure to give.

By filers reporting in the year to 30 June 2026, MapLight Therapeutics, Inc. was number 4,617 of 11,972 companies with a page and votes in that year. No filer reported votes at MapLight Therapeutics, Inc. in the year to 30 June 2025, so this page gives no change from that year. In all seasons on file, category DIRECTOR ELECTIONS is 75.0% of the vote records at MapLight Therapeutics, Inc.. At all companies on this site, it is 52.2%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 23 Jun 2026

63 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 81.6% of the reported votes are for. 34 filers withheld from or voted against at least one nominee.

    360 vote records from 63 filers. 2 of the 62 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 28 fund families
    • For 25
    • Abstain or withhold 2
    • Split or no vote 1
    • Against management 2
  2. Item 2: Audit-related items (auditor ratification)

    120 vote records from 63 filers. 0 of the 62 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 28 fund families
    • For 27
    • Split or no vote 1

Positions of the fund families at the meeting of 23 Jun 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at MapLight Therapeutics, Inc., meeting of 23 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familyAuditor
American CenturyFor
BlackRock and iSharesFor
Brighthouse FundsFor
Capital Group and American FundsFor
Charles SchwabFor
DWSFor
EquitableFor
FidelityFor
Global XFor
Goldman SachsFor
Guggenheim and RydexFor
Janus HendersonFor
John Hancock and ManulifeFor
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertFor
NationwideFor
Northern Trust and FlexSharesSplit
Nuveen and TIAAFor
Pacific Life fundsFor
PrincipalFor
ProShares and ProFundsFor
SEIFor
State Street and SPDRFor
T. Rowe PriceFor
TransamericaFor
VanguardFor
Victory CapitalFor
VoyaFor

Every meeting on file

Meetings of MapLight Therapeutics, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026632not reported

Say-on-pay, season by season

Say-on-pay at MapLight Therapeutics, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202663not reportednot reported
MapLight Therapeutics, Inc. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against managementnot reported6.6%
Reported shares against managementnot reported2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at MapLight Therapeutics, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS36075.0%
AUDIT-RELATED12025.0%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at MapLight Therapeutics, Inc.. https://votescores.com/company/maplight-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of MapLight Therapeutics, Inc. are on file?
1 meeting is on file, on 23 Jun 2026. 1 meeting has 20 or more reporting filers and has its own page.
Did filers report proposals from security holders at MapLight Therapeutics, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. MapLight Therapeutics, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list MapLight Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The ticker and the SEC company number come from the SEC company tickers file, matched on the exact name. The filers wrote the filings. Filings read through .